WO1994027985A1 - Procede de preparation de 3-halomethyl-benzothiophenes, -benzofuranes et -indoles substitues et intermediaires associes - Google Patents
Procede de preparation de 3-halomethyl-benzothiophenes, -benzofuranes et -indoles substitues et intermediaires associes Download PDFInfo
- Publication number
- WO1994027985A1 WO1994027985A1 PCT/US1994/005929 US9405929W WO9427985A1 WO 1994027985 A1 WO1994027985 A1 WO 1994027985A1 US 9405929 W US9405929 W US 9405929W WO 9427985 A1 WO9427985 A1 WO 9427985A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- alkyl
- formula
- process according
- bromide
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
Definitions
- 4,959,360, 4,963,547, 4,978,660, and 5,006,521 may be prepared from C 1-2 alkyl
- this invention is a process for preparing compounds of formula (I):
- X 1 , X 2 , and X 3 independently are any accessible combination of H, Cl, Br, F, I, CF 3 , C 1-6 alkyl, COR2, CO 2 R 2 , CONR 2 R 2 , CN, NO 2 , NR 3 R 4 , OR 3 , SC 1-4 alkyl, S(CH 2 ) 0-6 phenyl or SCF 3 ;
- Y is Br or Cl
- A is S, O, or NH
- each R 2 independently is C 1-6 alkyl or (CH 2 ) 0-6 phenyl;
- each R 3 independently is H, C 1-6 alkyl, COR 2 , or SO 2 R 2 ;
- R 4 is H or C 1-6 alkyl
- R 5 is C 1-6 alkyl,C 3-5 alkenyl, or (CH 2 ) 0-6 Phenyl; which comprises reacting a compound of the formula (II):
- X 1 , X 2 , X 3 , A and R 1 are as defined above for formula (I),
- a feature of this invention is novel intermediate compounds of the formula (VI):
- X 1 is H, Cl, Br, F, I, CF 3 , C 1-6 alkyl, COR 2 , CO 2 R 2 , CONR 2 R 2 , CN, NO 2 , NR 3 R 4 , OR 3 , SC 1-4 alkyl, S(CH 2 ) 0-6 phenyl or SCF 3 ;
- Y is Br or Cl
- A is S, O, or NH.
- the present invention discloses useful intermediates and a process for the preparation of compounds of formula (I):
- X 1 , X 2 , and X 3 independently are any accessible combination of H, Cl, Br, F, I, CF 3 , C 1-6 alkyl, COR 2 , CO 2 R 2 , CONR 2 R 2 CN, NO 2 , NR 3 R 4 , OR 3 ,
- SC 1-4 alkyl S(CH 2 ) 0-6 phenyl or SCF 3 ;
- Y is Br or Cl
- A is S, O, or NH
- each R 2 independently is C 1-6 alkyl or (CH 2 ) 0-6 phenyl;
- each R 3 independently is H, C 1-6 alkyl, COR 2 , or SO 2 R 2 ;
- R 4 is H or C 1-6 alkyl; and R 5 is C 1-6 alkyl,C 3-5 alkenyl, or (CH 2 ) 0-6 phenyl; which comprises reacting a compound of the formula (II):
- X 1 , X 2 , X 3 , A and R 1 are as defined above for formula (I), with a halomethylating agent, in the presence of a phase-transfer catalyst.
- alkyl and alkenyl mean carbon chains which are branched or unbranched with the length of the chain determined by the descriptor preceding the term.
- the process can be used to prepare compounds according to formula (III):
- A, Y and R 1 are as defined above for formula (I);
- X 1 is H, Cl, Br, F, I, CF 3 , C 1-6 alkyl, COR 2 , CO 2 R 2 , CONR 2 R 2 , CN,
- a and R 1 are as defined in formula (I);
- X 2 is defined in formula (III).
- the process can be used to prepare compounds of formula (III) in which X 1 is Cl, Br, F, or I, A is S or O, and R 1 is C 1-6 alkyl.
- the process can be used to prepare formula (III) compounds in which X 1 is Cl, A is S, R 1 ethyl and Y is Br, which is 2-ethyl-3-bromomethyl-5-chlorobenzo[b]thiophene.
- the reaction is carried out on compounds of formula (II) in which X 1 , X 2 , X 3 , A and R 1 are as required in the formula (I) product.
- the process is conducted with formula (IN) compounds.
- phase-transfer catalyst used in the present invention is a quaternary salt of the formula (N): (R') 4 M + U- (V) wherein:
- M is nitrogen, arsenic, phosphorous, antimony, or bisbuth
- each R' independently is C 1-25 alkyl, with the total carbon content of (R') 4 being greater than 16 carbon atoms, but not greater than 50 carbon atoms.
- M is a pentavalent ion
- R 1 is an organic portion of the salt molecule bonded to M by four covalent linkages
- U- is an anion.
- the preferred halide quaternary salts are those wherein M is nitrogen and U is Cl or Br.
- Suitable quaternary salts are cetyltrimethylammonium bromide, myristyltrimethylammonium bromide, cetyltrimethylammonium chloride, cetyldimethylethylammonium bromide, cetyltrihexylammonium bromide, trioctylethylammonium bromide, tridecylmethylammonium chloride,
- the preferred quaternary salts are cetyltrimethylammonium bromide or myristyltrimethylammonium bromide.
- the halomethylating agent used in the present invention is generated from formaldehyde, or an equivalent thereof, and aqueous hydrobromic or hydrochloric acid.
- the halomethylating agent is generated from formaldehyde, formalin or 1, 3, 5-trioxane, preferably 1, 3, 5-trioxane, and 48% hydrobromic acid in glacial acetic acid.
- the process is carried out by reacting a 2-substituted- benzo[b]thiophene, -benzo[b]furan, or -indole, preferably 2-ethyl-5-chlorobenzo[b]thiophene, with a halomethylating agent, preferably generated from 1, 3, 5-trioxane and 48% hydrobromic acid in glacial acetic acid, in the presence of a phase-transfer catalyst, such as a quaternary salt, preferably
- cetyltrimethylammonium bromide or myristyltrimethylammonium bromide are examples of cetyltrimethylammonium bromide or myristyltrimethylammonium bromide.
- novel intermediates of formula (VI) are prepared by reacting a
- a phase-transfer catalyst for example cetyltrimethylammonium bromide or myristyltrimethylammonium bromide.
- the formula (II) and (IV) compounds are prepared from the appropriately substituted phenol, thiophenol or aniline starting materials, such as 4-chlorothiophenol, in a reaction with ⁇ -bromobutyraldehyde diethyl acetal, followed by acid-catalyzed cyclization.
- the flask was then allowed to warm to room temperature, and sodium iodide (67.6 g, 0.451 mol) and ⁇ -bromobutyraldehyde diethyl acetal (1015.33 g, 4.51 mol) were added bulkwise over 15 min.
- the reaction was heated to reflux for 18 hr. and then checked by GC [120°(1)/15° min/275° (5); DB-1, 15 meter column] for the disappearance of the starting materials.
- the reaction was allowed to heat under reflux 2 hr. more and then allowed to cool to room temperature.
- the reaction solution was partitioned between ethyl acetate and water (3.0 L each).
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
L'invention se rapporte à de nouveaux intermédiaires et procédés destinés à la préparation d'intermédiaires utiles répondant à la formule (I) et aptes à être utilisés pour la synthèse d'agents à activité pharmaceutique.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6891493A | 1993-05-28 | 1993-05-28 | |
US08/068,914 | 1993-05-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1994027985A1 true WO1994027985A1 (fr) | 1994-12-08 |
Family
ID=22085524
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1994/005929 WO1994027985A1 (fr) | 1993-05-28 | 1994-05-26 | Procede de preparation de 3-halomethyl-benzothiophenes, -benzofuranes et -indoles substitues et intermediaires associes |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO1994027985A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0919552A1 (fr) * | 1996-07-24 | 1999-06-02 | Teikoku Hormone Mfg. Co., Ltd. | Procede de preparation de composes de benzothiophene 2,6-disubstitue |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2553495A (en) * | 1950-05-04 | 1951-05-15 | Nat Drug Co | N-(3-benzothenyl)-n-ethyl-betachloroethylamine adrenolytic |
US3331854A (en) * | 1964-12-14 | 1967-07-18 | American Cyanamid Co | Novel furan and thiophene compounds |
US5196429A (en) * | 1986-12-31 | 1993-03-23 | Hoechst-Roussel Pharmaceuticals Inc. | Method of inhibiting the activity of leukocyte derived cytokines |
-
1994
- 1994-05-26 WO PCT/US1994/005929 patent/WO1994027985A1/fr active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2553495A (en) * | 1950-05-04 | 1951-05-15 | Nat Drug Co | N-(3-benzothenyl)-n-ethyl-betachloroethylamine adrenolytic |
US3331854A (en) * | 1964-12-14 | 1967-07-18 | American Cyanamid Co | Novel furan and thiophene compounds |
US5196429A (en) * | 1986-12-31 | 1993-03-23 | Hoechst-Roussel Pharmaceuticals Inc. | Method of inhibiting the activity of leukocyte derived cytokines |
Non-Patent Citations (10)
Title |
---|
CHEMCIAL ABSTRACTS, Volume 87, issued 1977, ARESCHKA et al., "Studies on the Benzofuran Series", Abstract No. 102105. * |
CHEMICAL ABSTRACTS, Volume 77, issued 1972, ARESCHKA et al., "Benzofurans. Benzofurarylmethylimidazolines", Abstract No. 164591. * |
CHEMICAL ABSTRACTS, Volume 77, issued 1972, BINON et al., "2-Ä (2-Alkylbenzofuran)MethylÜ-2-Imidazolones", Abstract No. 140068. * |
CHEMICAL ABSTRACTS, Volume 80, issued 1973, DESCAMPS et al., "Antihypertensive Acetamidine Derivatives", Abstract No. 96017. * |
CHEMICAL ABSTRACTS, Volume 80, issued 1973, KHILYA et al., "Synthesis and Properties of Heterocyclic Analogs of Isoflavones", Abstract No. 59825. * |
CHEMICAL ABSTRACTS, Volume 85, issued 1976, ARESCHKA et al., "New Piperazine Amidines and Related Compounds", Abstract No. 160029. * |
CHEMICAL ABSTRACTS, Volume 85, issued 1976, WITIAK et al., "Synthesis and Antilipidemic Properties of Cis-7-Chloro-3a,8b-Dihydro.....Benzofuran", Abstract No. 116536. * |
CHEMICAL ABSTRACTS, Volume 99, issued 1983, CROSS et al., "Thromboxane Synthetase Inhibitors and Pharmaceutical Compositions Comprising Them", Abstract No. 105247. * |
J. MARCH, "Advanced Organic Chemistry", 4th Edition, Published 1992, by WILEY-INTERSCIENCE (N.Y.), see pages 362-363. * |
J. MCMURRY, "Organic Chemistry", 2nd Edition, Published 1988, by BROOKS/COLE (CA), see pages 1039-1040. * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0919552A1 (fr) * | 1996-07-24 | 1999-06-02 | Teikoku Hormone Mfg. Co., Ltd. | Procede de preparation de composes de benzothiophene 2,6-disubstitue |
EP0919552A4 (fr) * | 1996-07-24 | 1999-09-15 | Teikoku Hormone Mfg Co Ltd | Procede de preparation de composes de benzothiophene 2,6-disubstitue |
US6020531A (en) * | 1996-07-24 | 2000-02-01 | Teikoku Hormone Mfg. Co., Ltd. | Process for the preparation of 2,6-disubstituted benzothiophene compounds |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1167036A (fr) | Synthese de benzothiophenes acyles | |
US8748636B2 (en) | Process for preparing benzofuran derivatives substituted at position 5 | |
CA1130296A (fr) | Obtention et emploi pharmaceutique de composes du type hydroxypropyl-triazole | |
CH616161A5 (fr) | ||
HU200740B (en) | Process for producing alkadiene derivatives and pharmaceutical compositions comprising same | |
WO1994027985A1 (fr) | Procede de preparation de 3-halomethyl-benzothiophenes, -benzofuranes et -indoles substitues et intermediaires associes | |
JP2012516868A (ja) | 2−ハロゲノメチルフェニル酢酸誘導体の製造方法 | |
US4158007A (en) | Carbazole methyl malonates | |
US4154743A (en) | 3-Oxobenzofuranyl-2-idenyl, haloacetic acids | |
WO2008139057A2 (fr) | Procede de preparation de 2-(n-butyl)-3-(4-hydroxybenzoyl)-5-nitrobenzofurane | |
HU208533B (en) | Process for selective etherification of ascorbinic acid derivatives | |
JPH0794420B2 (ja) | 置換フェノキシアセトアルデヒドオキシム類の製造方法 | |
HU208320B (en) | Process for producing 0-carboxypyridyl and 0-carboxyquinolyl imidazolinones | |
US5580989A (en) | Process for the preparation of N-4-[(substituted phenyl)alkylheterocyclic]-N | |
CZ61093A3 (en) | BENZOL(b)THIOPHEN-5-YL DERIVATIVES, AND PROCESS FOR PRODUCING THEREOF | |
CA1197511A (fr) | Haloalkyl-8-4h-¬1|-benzopyran-4-ones, et procede de preparation | |
US4891433A (en) | Process for the preparation of dibenzothiepin derivative | |
GB2120663A (en) | Allylamine derivatives, processes for their preparation and their use | |
US4931574A (en) | Process for the preparation of benzopyrans | |
CA1119179A (fr) | Procede d'obtention de composes a base de n-tritylimidazole | |
US4334088A (en) | 2-Alkynyl-5-indanyloxyacetic acids | |
JP3534816B2 (ja) | メチルチオベンゼン類の製造方法 | |
US4982008A (en) | Process for preparing p-bromophenoxyacetaldehyde dialkylacetal compounds | |
US4226774A (en) | Carbazole melonates | |
US4193923A (en) | Tetrahydro 2-carbazolyl methyl malonate derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |